Experts have highlighted the potential of irpagratinib to become the first truly precision-targeted therapy for liver cancer. With FDA fast track designation now in place, Abbisko Therapeutics plans ...
Results from a new clinical trial led by Wake Forest University School of Medicine and Atrium Health Levine Cancer show that ...
The National Cancer Institute, the federal research agency charged with leading the war against the nation’s second-largest killer, is studying ivermectin as a potential cancer treatment, according to ...
The UK government has set out to improve access to healthcare technology within the National Health Service (NHS) through the new National Healthtech Access Programme (NHAP).
Long favored in SPF overseas, the photostable and highly wearable bemotrizinol could be the newest addition to the archaic U.S. sunscreen market.
Consumer Reports reveals that some shampoos, deodorants, lotions or makeup may contain ingredients linked to cancer risk, ...
Comprehensive review aims to clarify growing public concern around Ozempic®, Wegovy®, and Mounjaro®TAMPA, Fla., Feb. 10, 2026 /PRNewswire/ -- With the ...
AHA Statement before the House Committee on Energy and Commerce Health Subcommittee on “Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain” ...
The gut microbiota plays a crucial role in regulating host immunity, metabolism and inflammation, with accumulating evidence ...
Investor's Business Daily on MSN
AstraZeneca reiterates $80 billion 2030 view ahead of 'catalyst-rich 2026'
AstraZeneca stock rose moderately Tuesday morning on better-than-expected sales and profit in the fourth quarter.
Several well-known UK retailers have closed stores or restructured in early 2026 Fashion, discount, charity and gaming chains ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results